Biosynthesis and role of filoviral glycoproteins

Journal of General Virology

Volumn 82, Issue 12, 2001, Pages 2839-2848

  Feldmann, H ^a   Volchkov, V E ^a   Volchkova, V A ^a   Stroher U ^a   Klenk, H D ^a  

^a Canadian Science Centre for Human and Animal Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; CELL DESTRUCTION; CONTROLLED STUDY; FILOVIRUS; HOST RESISTANCE; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; VIRUS PATHOGENESIS;

MARBURG-LIKE VIRUSES;

EID: 0035200932     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-12-2839     Document Type: Review

References (85)

1. Inhibition of HIV-1 gp 160-dependent membrane fusion by a furin-directed α1-antitrypsin variant
2. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus
3. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells
4. The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: A comparison with the Musoke (1980) strain
5. Structure of influenza haemagglutinin at the pH of membrane fusion
6. Fighting the Ebola virus
7. Core structure of gp41 from the HIV envelope glycoprotein
8. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
9. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
10. Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses
11. Crystal structure of the matrix protein VP40 from Ebola virus
12. Marburg and Ebola viruses
13. Classification, structure, and replication of filoviruses
14. Glycosylation and oligomerization of the spike protein of Marburg virus
15. Marburg virus, a filovirus: Messenger RNAs, gene order, and regulatory elements of the replication cycle
16. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein
17. Filoviruses
18. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis
19. HIV-1 entry cofactor: Fnctional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
20. Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain
21. Acylation of the Marburg virus glycoprotein
22. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses
23. Differentiation of filoviruses by electron microscopy
24. Carbohydrate structure of Marburg virus glycoprotein
25. Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants
26. Immune response to filovirus infections
27. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein
28. Ebola virus glycoprotein: Proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies
29. A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41
30. Ebola virus secretory glycoprotein (sGP) diminishes FcγRIIIB-to-CR3 proximity on neutrophils
31. Will we have and why do we need an Ebola vaccine?
32. Activation cleavage of viral spike proteins by host proteases
33. Host cell proteases controlling virus pathogenicity
34. Two strings to the bow of Ebola virus
35. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9 Å resolution
36. Marburg virus penetration into eukaryotic cells
37. Ebola virus, neutrophils and antibody specificity
38. Ebola virus can be effectively neutralized by antibody produced in natural human infection
39. Intracellular trafficking and activation of the furin proprotein convertase: Localization to the TGN and recycling from the cell surface
40. Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes
41. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems
42. Treatment of Ebola haemorrhagic fever with blood transfusions from convalescent patients
43. Generation of Ebola virus entirely from cloned cDNA: New opportunities in experimental filovirus research
44. Ebola: The virus and the disease
45. Filoviridae: Marburg and Ebola viruses
46. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola haemorrhagic fever virus
47. Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus
48. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus
49. An analysis of features of pathogenesis in two animal models of Ebola virus infection
50. Sequence analysis of the Ebola virus genome: Organization, genetic elements, and comparison with the genome of Marburg virus
51. The virion glycoprotein of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing
52. Variation in the glycoprotein and VP35 genes of Marburg virus strains
53. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus
54. Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin
55. Molecular pathogenesis of filovirus infections: Role of macrophages and endothelial cells
56. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases
57. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion
58. Influenza virus haemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease
59. Development of a preventive vaccine for Ebola virus infection in primates
60. A system for functional analysis of Ebola virus glycoprotein
61. Downregulation of β1 integrins by Ebola virus glycoprotein: Implication for virus entry
62. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge
63. Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin
64. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses
65. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases
66. Processing of the Ebola virus glycoprotein by the proprotein convertase furin
67. Release of viral glycoproteins during Ebola virus infection
68. Molecular characterization of guinea pig-adapted variants of Ebola virus
69. Proteolytic processing of Marburg virus glycoprotein
70. Recovery of infectious Ebola virus from cDNA: Transcriptional RNA editing of the GP gene controls viral cytotoxicity
71. The nonstructural small glycoprotein of Ebola virus is secreted as an antiparallel-orientated homodimer
72. δ-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus
73. Functional importance of the coiled-coil of the Ebola virus glycoprotein
74. Atomic structure of the ectodomain from HIV-1 gp41
75. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil
76. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain
77. Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein
78. Epitopes involved in antibody-mediated protection from Ebola virus
79. Expression of a human proprotein processing enzyme: Correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site
80. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines
81. Endoproteolytic processing of the Ebola virus envelope glycoprotein: Cleavage is not required for function
82. Immunization for Ebola virus infection
83. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins
84. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury